There is no Press for this Ticker
Transgene SA is a biotechnology company. It is involved in the business of discovering and focusing immune-targeted therapies for the treatment of cancer and infectious diseases. The company's lead clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. The firm is based in Strasbourg, France has additional operations in Lyon as well as satellite offices in China and United States. Its subsidiary represents the company before various bodies, regulatory authorities and clinical sites for clinical trials it conducts in the US.

Related Companies

TickerCompanyChg %Mkt Cap
TRGNFTransgene0%267.9M

Transgene Company Questions & Answers

Q

How do I buy Transgene (TRGNF) stock?

A

You can purchase shares of Transgene (OTC: TRGNF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Transgene's (TRGNF) main competitors?

A

There are no as such competitors for Transgene.

Q

What is the target price for Transgene?

A

There is no analysis for Transgene

Q

How much is Transgene (TRGNF) stock ?

A

The stock price for Transgene (OTC: TRGNF) is $3.195 last updated Wed Mar 31 2021 17:58:14 GMT+0000 (Coordinated Universal Time).

Q

When is the next Transgene (TRGNF) dividend?

A

There are no upcoming dividends for Transgene.

Q

When is Transgene (OTC:TRGNF) reporting earnings?

A

There are no earnings for Transgene

Q

When is the upcoming split for TRGNF?

A

There is no upcoming split for Transgene.